Results 201 to 210 of about 180,278 (321)

Induction and analysis of CTL for autochthonous tumor.

, 1991
佐藤 昇志, 菊地 浩吉
openalex   +2 more sources

Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1) [PDF]

, 1998
Jack da Silva, A. Hughes
openalex   +1 more source

MiR‐221‐3p Attenuates IL‐33‐Induced Mast Cell Cytokine Expression by Targeting KIT

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Mast cells (MCs) are involved in type 2 inflammation in chronic rhinosinusitis with nasal polyps (CRSwNP), which depends on interleukin (IL)‐33 stimulation. MiR‐221 is reported to be an important regulator of MCs, and miR‐221‐3p can be expressed in CRSwNP. However, the role of miR‐221‐3p in CRSwNP is unclear. Methods Ethmoid tissues
Ruowu Liu, Jiao Zhou, Jing Zhou, Feng Liu, Yafeng Liu, Juan Meng, Luo Ba, Hengyi Xiao, Shixi Liu, Nan Zhang, Claus Bachert, Jintao Du   +11 more
wiley   +1 more source

Tissue‐resident CD69+CXCR6+ Natural Killer cells with exhausted phenotype accumulate in human non‐small cell lung cancer

European Journal of Immunology, Volume 52, Issue 12, Page 1993-2005, December 2022., 2022
This study identified a CD69+CXCR6+ tissue‐resident NK (trNK) subset specifically accumulated in the tumor microenvironment of human non‐small cell lung cancer patients. CD69+CXCR6+ trNK cells showed an immunomodulatory‐like and exhaustion phenotype, and secreted IFN‐γ and TNF‐α rapidly. Abstract Natural killer (NK) cells with tissue‐residency features
Xiaoke Chen, Yongyuan Chen, Zhongwei Xin, Mingjie Lin, Zhixing Hao, Di Chen, Teng He, Lufeng Zhao, Dang Wu, Pin Wu, Ying Chai   +10 more
wiley   +1 more source

Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients. [PDF]

Cell Death Dis
Amato L, De Rosa C, Di Guida G, Sepe F, Ariano A, Capaldo S, Ul Haq F, Di Liello A, Tuccillo C, Lucà S, Franco R, De Rosa V, Iommelli F, Servetto A, Ciardiello F, Della Corte CM, Morgillo F.   +16 more
europepmc   +1 more source

369 Safety and pharmacodynamic activity of ATOR-1015, a CTLA-4 x OX40 bispecific antibody, in a phase 1 dose escalation study of patients with advanced solid malignancies

Journal for ImmunoTherapy of Cancer, 2020
Gustav Ullenhag, Anne Månsson Kvarnhammar, Charlotte Russell, Jeffrey Yachnin, Ana Carneiro, Dorte Nielsen, Kristoffer Staal Rohrberg, Lena Schultz, Erika Bågeman, Camilla Wennersten   +9 more
doaj   +1 more source

CTL self-defence [PDF]

Nature Reviews Molecular Cell Biology, 2002
openaire   +4 more sources

Investigation of the optimal condition for the induction of Cytotoxic T Lymphocytes(CTL) and application of CTL to gynecologic malignancies.

, 1992
Hiroshi Tsuda, Naohiko Umesaki
openalex   +2 more sources

Anti‐L‐selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area [PDF]

, 1996
Antonio Rosato, Annalisa Zambon, Beatrice Macino, Susanna Mandruzzato, Vincenzo Bronte, Gabriella Milan, Paola Zanovello, Dino Collavo   +7 more
openalex   +1 more source

Exploring the co‐morbid relationship between Alzheimer's disease and lung cancer in the 5xFAD transgenic mouse model

Animal Models and Experimental Medicine, EarlyView.
Schematic diagram of inverse comorbidities of Alzheimer's disease and lung cancer. Abstract Background Alzheimer's disease (AD) and lung cancer are leading causes of mortality among the older population. Epidemiological evidence suggests an antagonistic relationship between them, whereby patients with AD exhibit a reduced risk of developing cancer and ...
Mingfeng Li, Xinghan Wu, Lin Jiang, Min Liu, Gong Yanju, Xiaomeng Li, Fan Tian, Fan Ye, Jinlong Wang, Siyuan Wang, Chuan Qin, Ling Zhang   +11 more
wiley   +1 more source